Matinas BioPharmaBedminster, New Jersey, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
LB1580 - Efficacy Assessment of MAT2203 Encochleated Oral Formulation of Amphotericin B, in the Neutropenic Mouse Model of Pulmonary Mucormycosis
Friday, October 21, 20224:03 PM - 4:15 PM US ET